» Articles » PMID: 33953703

Case Report: An Atypical Form of Familial Partial Lipodystrophy Type 2 Due to Mutation in the Rod Domain of Lamin A/C

Overview
Specialty Endocrinology
Date 2021 May 6
PMID 33953703
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Familial partial lipodystrophy type 2 (FPLD2) patients generally develop a wide variety of severe metabolic complications. However, they are not usually affected by primary cardiomyopathy and conduction system disturbances, although a few cases of FPLD2 and cardiomyopathy have been reported in the literature. These were all due to amino-terminal heterozygous lamin A/C mutations, which are considered as new forms of overlapping syndromes.

Methods And Results: Here we report the identification of a female patient with FPLD2 due to a heterozygous missense variant c.604G>A in the exon 3 of the gene, leading to amino acid substitution (p.Glu202Lys) in the central alpha-helical rod domain of lamin A/C with a high propensity to form coiled-coil dimers. The patient's cardiac evaluations that followed the genetic diagnosis revealed cardiac rhythm disturbances which were promptly treated pharmacologically.

Conclusions: This report supports the idea that there are "atypical forms" of FPLD2 with cardiomyopathy, especially when a pathogenic variant affects the lamin A/C head or alpha-helical rod domain. It also highlights how increased understanding of the genotype-phenotype correlation could help clinicians to schedule personalized monitoring of the lipodystrophic patient, in order to prevent uncommon but possible devastating manifestations, including arrhythmias and sudden death.

Citing Articles

Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.

Besci O, Foss de Freitas M, Guidorizzi N, Celik Guler M, Gilio D, Maung J J Clin Endocrinol Metab. 2023; 109(3):e1204-e1224.

PMID: 37843397 PMC: 10876415. DOI: 10.1210/clinem/dgad606.


Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report.

Cecchetti C, Belardinelli E, Dionese P, Teglia R, Fazzeri R, D Apice M Front Endocrinol (Lausanne). 2023; 14:1190363.

PMID: 37347108 PMC: 10281053. DOI: 10.3389/fendo.2023.1190363.


Next-Generation Sequencing of a Large Gene Panel for Outcome Prediction of Bariatric Surgery in Patients with Severe Obesity.

Bonetti G, Dhuli K, Ceccarini M, Kaftalli J, Samaja M, Precone V J Clin Med. 2022; 11(24).

PMID: 36556146 PMC: 9783894. DOI: 10.3390/jcm11247531.

References
1.
Fatkin D, MacRae C, Sasaki T, WOLFF M, Porcu M, Frenneaux M . Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999; 341(23):1715-24. DOI: 10.1056/NEJM199912023412302. View

2.
Valerio C, Zajdenverg L, de Oliveira J, Mory P, Moyses R, Godoy-Matos A . Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012; 4(1):40. PMC: 3524775. DOI: 10.1186/1758-5996-4-40. View

3.
Fanelli F, Gambineri A, Belluomo I, Repaci A, Di Lallo V, Di Dalmazi G . Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. J Clin Endocrinol Metab. 2013; 98(7):3058-67. DOI: 10.1210/jc.2013-1381. View

4.
Lattanzi G, Maggi L, Araujo-Vilar D . Laminopathies. Nucleus. 2019; 9(1):543-544. PMC: 7000148. DOI: 10.1080/19491034.2018.1515606. View

5.
Garg A, Vinaitheerthan M, Weatherall P, Bowcock A . Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. J Clin Endocrinol Metab. 2001; 86(1):59-65. DOI: 10.1210/jcem.86.1.7121. View